Xarelto Side Effect Litigation: Special Report

  • March 13, 2024

Understanding the Basics: What is Xarelto?

Xarelto, scientifically known as rivaroxaban, is a blood-thinning medicine produced by Janssen Pharmaceuticals and Bayer. It’s used primarily in prevention and treatment of blood clot formation in various medical conditions such as deep vein thrombosis (DVT) and atrial fibrillation.

Exploring the Medical Uses of Xarelto

Xarelto is used in a variety of medical capacities. Doctors prescribe it to prevent blood clots in patients undergoing hip or knee replacement surgeries. Furthermore, it’s an essential tool in the battle against pulmonary embolism, stroke, and cardiovascular issues correlated with increased clotting risks.

Diving Deeper: Unpacking the Side Effects of Xarelto

While Xarelto provides undeniable advantages, it’s not without side effects. Examples of potential problems include severe bleeding, spinal or epidural blood clots, and wound complications post surgery. In some cases, it may even lead to death. Realizing these potential risks is essential for anyone taking Xarelto.

Behind the Courtroom Doors: The Beginning of Xarelto Litigations

Litigations against the manufacturers of Xarelto began when patients experiencing severe side effects filed lawsuits. They claim that Janssen Pharmaceuticals did not adequately warn users about the potential risks. Up till now, there have been thousands of lawsuits filed, and millions of dollars paid in settlement.

Where We Stand: Recent Developments in Xarelto Litigations

Recent years have seen significant developments in Xarelto litigations. Many cases have been consolidated into a mass tort program in the Philadelphia Court of Common Pleas. Furthermore, the manufacturers have settled for $775 million to resolve all the pending cases – without any admission of liability.

Final Thoughts: Moving Forward with Xarelto Litigations

Moving forward, it is likely that Xarelto litigation will continue to adapt and evolve. What the future holds for these cases remains unclear; however, one thing is sure – the manufacturers will be under constant scrutiny to ensure adequate safety warnings are constructed. As for patients, those considering Xarelto should converse with their healthcare providers about its potential risks and benefits.


Press ESC to close